期刊文献+

L-精氨酸脂质体对慢性低O_2高CO_2肺动脉高压大鼠的影响 被引量:1

Effect of L-arginine liposome on the pulmonary hypertension in rats chronically exposed to hypoxia and hypercapnia
下载PDF
导出
摘要 目的 :观察L 精氨酸 (L Arg)脂质体对慢性低氧高二氧化碳性肺动脉高压、右心室肥大大鼠的影响并探讨其机制。方法 :将 4 0只健康雄性SD大鼠随机分为 4组 :正常对照组 (NC组 )、低氧高二氧化碳 4w组 (HH组 )、低氧高二氧化碳加L Arg 4w组 (LA组 )和低氧高二氧化碳加L Arg脂质体 4w组 (LL组 )。采用化学比色法测定肺组织匀浆eNOS活性 ,用液体闪烁仪测定 [3 H] 瓜氨酸的生产量 ,计算肺动脉总一氧化氮合酶 (tNOS)的活性 ,组织原位杂交观测肺细小动脉eNOSmRNA的表达变化。结果 :①HH组平均肺动脉压力(mPAP)和右心室重量与左心室加室间隔重量比 (RV/LV +S)均高于NC组 ,LL组均明显低于LA组与HH组。②HH组的肺组织匀浆tNOS含量明显高于NC组 (P <0 .0 1) ,LL组高于LA组 (P <0 .0 5 ) ,而LA组与HH组无明显差异。③HH组的肺动脉tNOS活性显著高于NC组 (P <0 .0 1) ,而LL、LA、HH三组的tNOS活性之间均无明显差异 (P >0 .0 5 )。④HH组的肺细小动脉eNOSmRNA的平均吸光度值低于NC组 (P <0 .0 5 ) ,LA组高于HH组 (P <0 .0 5 ) ,而LL组明显高于HH组和LA组 (P均 <0 .0 1)。结论 :L Arg脂质体较L Arg有更明显的降低慢性低氧高二氧化碳大鼠肺动脉压和减轻右室重构的作用 ,其机制可能与L Arg脂质体促进L Arg的跨膜转运有关。 Objective:To investigate the effects and mechanism of L-arginine liposome on rats of pulmonary hypertension and hypertrophy of right ventricular chronically exposed to hypoxia-hypercapnia.Methods:Fourty male Sprague-Dawley rats were randomly divided into four groups:normal control group (NC), hypoxia-hypercapnia group (HH), hypoxia-hypercapnia + L-arginine group (LA) and hypoxia-hypercapnia + L-arginine liposome group (LL).Contents of nitric oxide synthase (NOS) in pulmonary homogenates were measured with colorimetric analysis,and L-citrulline was determined with liquid scintillometer and the activities of tNOS were counted.The change of the expression of nitric oxide synthase gene was measured with situ hybridization.Results:①The mean pulmonary artery pressure(mPAP)and weight ratio of right ventricle to left ventricle and septum (RV/LV+S) of LL group were obviously lower than those of HH group and LA group.②The NOS contents in pulmonary homogenate of LL group were higher than those of LA group (P<0.05).③The tNOS activities in pulmonary arterioles were not changed among HH、LA and LL group(P>0.05). ④Situ hybridization showed the average value of integral light density (LD) of eNOS mRNA in pulmonary arterioles was significantly higher in rats of LL group than that of HH group and LA group(P<0.01).Conclusion:L-arginine liposome can lower the mPAP and lighten the remodeling of right ventricular of the rats chronically exposed to hypoxia-hypercapnia than L-arginine did. It suggests that L-arginine liposome may significantly promote the membrane transportion of L-arginine.
出处 《温州医学院学报》 CAS 2004年第2期85-88,共4页 Journal of Wenzhou Medical College
基金 浙江省卫生厅科研基金资助项目 (SWS960 0 5 ) 温州市科技局计划基金资助项目 (S2 0 0 1A2 4)
关键词 L-精氨酸 脂质体 一氧化氮合酶 低氧 高碳酸血 高血压 肺性 liposomes L-arginine nitric oxide synthase anoxia hypercapnia hypertension,pulmonary
  • 相关文献

参考文献8

二级参考文献16

  • 1戴爱国,张珍祥,牛汝楫,徐永健,段生福.缺氧对肺动脉内皮细胞一氧化氮合成酶活性及基因表达的影响[J].中华结核和呼吸杂志,1995,18(3):164-166. 被引量:16
  • 2薛全福,谢剑鸣.常压缺氧性大鼠肺动脉高压模型的建立[J].中华结核和呼吸杂志,1989,12(6):350-352. 被引量:157
  • 3Milsmann MH,Schwendener RA, Weder HG, et al. The pteperation of large single bilayer liposomes by a fast and controlled dialysis [J].Biochim Biophys Acta, 1978,512(1) : 147 - 155.
  • 4Szoka F, Olson F,Heath T, et al. Preparation of nnilamellar liposomes of intermediate size(0.1 -- 0.2 μm)by a combination of reverse phase evaporation and extrusion polycarmonate membranes[J]. Biochim Biophys Acta, 1980,601 (3) :559- 571.
  • 5Pavanetto F,Perugini P,Conti B,et al.Evaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion method[J].J Microencapsul,1996,13(6):679-688
  • 6Ohsawa T,Miura H,Harada K.Evalution of a new liposome preparation techinque.the freeze-thawing method,using L-asparaginase as a model drug[J].Chem Pharm Bull Tokyo,1985,33(7):2916-2923
  • 7强文宏,中华医学杂志,1997年,76卷,8期,568页
  • 8Xue C,Am J Physiol,1994年,267卷,Lung Cell Mol Physiol期,L667页
  • 9芮良优,中国应用生理学杂志,1990年,6卷,289页
  • 10Myers J L,Eur J Cardiothorac Surg,1998年,13卷,3期,298页

共引文献96

同被引文献25

  • 1许英梅,张树彪,韩双,胡剑钧,刘栋良,乔卫红,李宗石.阳离子脂质体在基因治疗中的应用[J].大连民族学院学报,2005,7(3):46-48. 被引量:4
  • 2Crystal R G.Sci[J],1995,270(5235):148-151.
  • 3Yosuke Obata,Daisuke S,Shinji T.Bioeonjugate Chem[J],2008,19(5)1055-1063.
  • 4Ma B C,Zhang S B,Jiang H M,et al.J of Controlled Release[J],2007,(123):184-194.
  • 5Zhang S B,Zhao Y N,Zhao B D,et al.Submitted to Bioconjugate Chem[J],2009,(12):1-16.
  • 6Dan N D,James H,Caroline J.Current Medic Chem[J],2003,(10):1233-1261.
  • 7Zhang S B,Xu Y M,Wang B,et al.J of Controlled Release[J],2004,100:165-180.
  • 8Zhou X H.,Huang L.Biochim Et Biophys Acta-Biomemb[J],1994,1189:195-203.
  • 9Folda T,Gros L,Ringsdorf H.Makromol Chem Rapid Commun[J],1982,(3):167.
  • 10Neumann R,Ringsdorf H.Am Chem Soc[J],1986,108:487.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部